NurExone Biologic Statistics
Total Valuation
TSXV:NRX has a market cap or net worth of CAD 53.83 million. The enterprise value is 52.87 million.
Market Cap | 53.83M |
Enterprise Value | 52.87M |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
Earnings Date | May 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:NRX has 78.01 million shares outstanding. The number of shares has increased by 46.27% in one year.
Current Share Class | n/a |
Shares Outstanding | 78.01M |
Shares Change (YoY) | +46.27% |
Shares Change (QoQ) | +11.89% |
Owned by Insiders (%) | 6.05% |
Owned by Institutions (%) | n/a |
Float | 73.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 21.24 |
P/TBV Ratio | 21.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.29 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.64 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.11 |
Quick Ratio | 2.08 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -313.07 |
Financial Efficiency
Return on equity (ROE) is -517.23% and return on invested capital (ROIC) is -195.66%.
Return on Equity (ROE) | -517.23% |
Return on Assets (ROA) | -135.79% |
Return on Invested Capital (ROIC) | -195.66% |
Return on Capital Employed (ROCE) | -245.18% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.50% in the last 52 weeks. The beta is 0.02, so TSXV:NRX's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | +17.50% |
50-Day Moving Average | 0.65 |
200-Day Moving Average | 0.64 |
Relative Strength Index (RSI) | 54.03 |
Average Volume (20 Days) | 12,540 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.21M |
Pretax Income | -7.26M |
Net Income | -7.26M |
EBITDA | -7.12M |
EBIT | -7.21M |
Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has 1.01 million in cash and 47,482 in debt, giving a net cash position of 959,706 or 0.01 per share.
Cash & Cash Equivalents | 1.01M |
Total Debt | 47,482 |
Net Cash | 959,706 |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 2.53M |
Book Value Per Share | 0.04 |
Working Capital | 1.78M |
Cash Flow
In the last 12 months, operating cash flow was -7.03 million and capital expenditures -933,807, giving a free cash flow of -7.97 million.
Operating Cash Flow | -7.03M |
Capital Expenditures | -933,807 |
Free Cash Flow | -7.97M |
FCF Per Share | -0.10 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSXV:NRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -46.27% |
Shareholder Yield | -46.27% |
Earnings Yield | -13.48% |
FCF Yield | -14.80% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |